Home / Recalls / Golden State Medical Supply Inc. / D-0158-2026

D-0158-2026 Class II Ongoing

Recalled by Golden State Medical Supply Inc. — Camarillo, CA

Recall Details

Product Type
Drugs
Report Date
November 26, 2025
Initiation Date
October 20, 2025
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
24,869 bottles

Product Description

NIACIN Extended-Release Tablets, USP, 1,000 mg, 90 tablets per bottle, Rx only, Manufactured by: Kremers Urban Pharmaceuticals, Inc., a subsidiary of Lannett Company, Inc., Seymour, IN 47274. Packaged by GSMS, Incorporated, Carmarillo, CA 93012. NDC: 51407-268-90

Reason for Recall

Failed Dissolution Specifications

Distribution Pattern

Nationwide in the USA

Code Information

Lot, expiry: GS044385, exp 10/2025 ; GS044979, exp 10/2025 ; GS045797, exp 12/2025 ; GS046415, exp 12/2025 ; GS047197, exp 02/2026 ; GS047786, exp 02/2026 ; GS048477, exp 02/2026 ; GS049480, exp 03/2026 ; GS048873, exp 03/2026 ; GS049733, exp 03/2026 ; GS050224, exp 03/2026 ; GS050721, exp 03/2026 ; GS050722, exp 03/2026 ; GS051145, exp 03/2026 ; GS051726, exp 03/2026 ; GS052484, exp 03/2026 ; GS053612, exp 04/2026 ; GS054987, exp 05/2026 ; GS054409, exp 05/2026 ; GS055697, exp 05/2026 ; GS056192, exp 05/2026 ; GS056886, exp 05/2026 ; GS058077, exp 05/2026 ; GS057330, exp 05/2026

Other recalls by Golden State Medical Supply Inc.

  • D-0235-2026 Class II — Baclofen Tablets USP, 10 mg, 1000-count bottles, Rx only, Marketed by: GSMS, Inc (November 26, 2025)
  • D-0287-2025 Class II — PRASUGREL TABLETS, 5 mg, 30 tablet bottles, Rx only, packaged by GSMS, Incorpora (March 5, 2025)
  • D-0568-2024 Class II — Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, a) 30 capsules bottles, (May 13, 2024)
  • D-0349-2024 Class II — Fluticasone Propionate Nasal Spray USP, 50 mcg per spray, 120 metered sprays, 16 (February 14, 2024)
  • D-0276-2024 Class II — Budesonide Extended-Release Tablets, 9 mg, 30-count bottles, Rx only, Marketed b (January 12, 2024)
  • D-0130-2024 Class II — PAROXETINE tablets, USP, 40 mg, Packaged as a) 30-count bottle, NDC 60429-737-3 (November 10, 2023)
  • D-0129-2024 Class II — PAROXETINE tablets, USP, 20 mg, Packaged as a) 90-count bottle NDC 60429-735-90; (November 10, 2023)
  • D-0128-2024 Class II — PAROXETINE tablets, USP, 10 mg, Packaged as a) 30-count bottle, NDC 60429-734-3 (November 10, 2023)
  • D-0867-2023 Class II — Travoprost Ophthalmic Solution, USP (Ionic Buffered Solution), 0.004%, Rx only, (May 25, 2023)
  • D-0011-2023 Class II — Rifampin Capsules, USP, 300 mg, packaged in a) 30-count bottle (NDC 51407-323-30 (October 6, 2022)